Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Bradycardia

3,4-dihydroxyphenylacetic acid has been researched along with Bradycardia in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delgado, M1
Caicoya, AG1
Greciano, V1
Benhamú, B1
López-Rodríguez, ML1
Fernández-Alfonso, MS1
Pozo, MA1
Manzanares, J1
Fuentes, JA1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Bradycardia

ArticleYear
Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    European journal of pharmacology, 2005, Mar-21, Volume: 511, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenylyl Cyclase Inhibitors;

2005